Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocera Therapeutics Inc (NASDAQ:OCRX)

1.16
Delayed Data
As of 3:21pm ET
 +0.0105 / +0.91%
Today’s Change
0.52
Today|||52-Week Range
3.15
-44.74%
Year-to-Date
No recent news for Ocera Therapeutics Inc.

Today’s Trading

Previous close1.15
Today’s open1.15
Day’s range1.11 - 1.20
Volume158,533
Average volume (3 months)1,741,492
Market cap$30.5M
Dividend yield--
Data as of 3:21pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)+18.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+357.89%
P/E ratioNM
Price/Sales75.72
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd+0.02+1.79%
MRNSMarinus Pharmaceutic...+0.03+2.17%
VKTXViking Therapeutics ...+0.02+1.81%
CATBCatabasis Pharmaceut...+0.07+4.96%
Data as of 3:35pm ET, 06/28/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$609.0K
Annual profit (last year)-$26.9M
Net profit margin-4,416.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Linda S. Grais
Chief Financial &
Principal Accounting Officer
Michael Byrnes
Corporate headquarters
Palo Alto, California

Forecasts